Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.
作者： Daniel Alcolea , Eduard Vilaplana , Jordi Pegueroles , Victor Montal , Pascual Sánchez-Juan
DOI: 10.1016/J.NEUROBIOLAGING.2015.03.001
关键词:
摘要: … with core Alzheimer's disease (AD) biomarkers. We measured cortical thickness (CTh) and … CTh difference maps were derived from the interaction and correlation analyses in the …
elsevier.com
sci-hub.se 参考文章(30)
Anna Antonell, Alicia Mansilla, Lorena Rami, Albert Lladó, Alex Iranzo, Jaume Olives, Mircea Balasa, Raquel Sánchez-Valle, José Luis Molinuevo, Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 42, pp. 901- 908 ,(2014) , 10.3233/JAD-140624
Daniel Alcolea, Pablo Martínez-Lage, Andrea Izagirre, Montserrat Clerigué, María Carmona-Iragui, Rosa María Alvarez, Juan Fortea, Mircea Balasa, Estrella Morenas-Rodríguez, Albert Lladó, Oriol Grau, Kaj Blennow, Alberto Lleó, José L. Molinuevo, Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: A Multicenter Study in Spain Journal of Alzheimer's Disease. ,vol. 39, pp. 719- 726 ,(2014) , 10.3233/JAD-131334
Daniel Alcolea, María Carmona-Iragui, Marc Suárez-Calvet, M. Belén Sánchez-Saudinós, Isabel Sala, Sofía Antón-Aguirre, Rafael Blesa, Jordi Clarimón, Juan Fortea, Alberto Lleó, Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease Journal of Alzheimer's Disease. ,vol. 42, pp. 157- 167 ,(2014) , 10.3233/JAD-140240
Juan Fortea, Eduard Vilaplana, Daniel Alcolea, María Carmona‐Iragui, María‐Belén Sánchez‐Saudinos, Isabel Sala, Sofía Antón‐Aguirre, Sofía González, Santiago Medrano, Jordi Pegueroles, Estrella Morenas, Jordi Clarimón, Rafael Blesa, Alberto Lleó, Alzheimer's Disease Neuroimaging Initiative, Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease. Annals of Neurology. ,vol. 76, pp. 223- 230 ,(2014) , 10.1002/ANA.24186
Rebecca Craig-Schapiro, Richard J. Perrin, Catherine M. Roe, Chengjie Xiong, Deborah Carter, Nigel J. Cairns, Mark A. Mintun, Elaine R. Peskind, Ge Li, Douglas R. Galasko, Christopher M. Clark, Joseph F. Quinn, Gina D'Angelo, James P. Malone, R. Reid Townsend, John C. Morris, Anne M. Fagan, David M. Holtzman, YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease Biological Psychiatry. ,vol. 68, pp. 903- 912 ,(2010) , 10.1016/J.BIOPSYCH.2010.08.025
Isabel Sala, María Belén Sánchez-Saudinós, Laura Molina-Porcel, Estela Lázaro, Ignasi Gich, Jordi Clarimón, Francisco Blanco-Vaca, Rafael Blesa, Teresa Gómez-Isla, Alberto Lleó, Homocysteine and cognitive impairment. Relation with diagnosis and neuropsychological performance. Dementia and Geriatric Cognitive Disorders. ,vol. 26, pp. 506- 512 ,(2008) , 10.1159/000173710
Anne M. Fagan, Mark A. Mintun, Robert H. Mach, Sang-Yoon Lee, Carmen S. Dence, Aarti R. Shah, Gina N. LaRossa, Michael L. Spinner, William E. Klunk, Chester A. Mathis, Steven T. DeKosky, John C. Morris, David M. Holtzman, Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Annals of Neurology. ,vol. 59, pp. 512- 519 ,(2006) , 10.1002/ANA.20730
Rahul S. Desikan, Linda K. McEvoy, Wesley K. Thompson, Dominic Holland, J. Cooper Roddey, Kaj Blennow, Paul S. Aisen, James B. Brewer, Bradley T. Hyman, Anders M. Dale, Amyloid-β associated volume loss occurs only in the presence of phospho-tau. Annals of Neurology. ,vol. 70, pp. 657- 661 ,(2011) , 10.1002/ANA.22509
R. C. Petersen, Mild cognitive impairment as a diagnostic entity Journal of Internal Medicine. ,vol. 256, pp. 183- 194 ,(2004) , 10.1111/J.1365-2796.2004.01388.X
D. Strozyk, K. Blennow, L. R. White, L. J. Launer, CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study Neurology. ,vol. 60, pp. 652- 656 ,(2003) , 10.1212/01.WNL.0000046581.81650.D0